You are here

Disable VAT on Taiwan

Unfortunately, as of 1 January 2020 SAGE Ltd is no longer able to support sales of electronically supplied services to Taiwan customers that are not Taiwan VAT registered. We apologise for any inconvenience. For more information or to place a print-only order, please contact uk.customerservices@sagepub.co.uk.

Psychedelic Medicine

Psychedelic Medicine


eISSN: 28314433 | ISSN: 28314425
This peer-reviewed, evidence-based resource solely focuses on psychedelic medicine. As psychedelic substances move into the mainstream with a growing number of clinical research programs, increasing industry investment, and accelerating legalization/decriminalization measures, this journal is the central authority with timely coverage on every aspect of psychedelic medicine. The journal provides rapid, fair peer review and welcomes original research papers including basic science, clinical, and translational research, as well as medical applications.

Psychedelic Medicine is the only peer-reviewed, evidence-based resource solely focused on this rapidly expanding area of research. As psychedelic substances move into the mainstream with a growing number of clinical research programs, increasing industry investment, and accelerating legalization/decriminalization measures – Psychedelic Medicine is the central authority with timely coverage on every aspect of psychedelic medicine.

Psychedelic Medicine provides rapid, fair peer-review, and welcomes original research papers including basic science, clinical, and translational research, as well as medical applications.

Psychedelic Medicine coverage includes:
Serotonin and serotonin receptors, signaling, functional selectivity, and ligand bias
Tryptamines (e.g. LSD, psilocybin, psilocin, DMT, 5-MeO-DMT)
Lysergamides (e.g. LSD)
Addiction
Animal models
Drug discovery
Effects on mental disorders
fMRI
Entactogens
Neuroplasticity
Palliative care
Phenethylamines (e.g. mescaline, DOI)
Psychiatry
Psychoactive substances (e.g. ibogaine)
Psychopharmacology
Psychotherapy
And more
Psychedelic Medicine is under the editorial leadership of Co-Editors-in-Chief: Peter Hendricks, PhD Professor and Director of Research, Department of Health Behavior, School of Public Health, University of Alabama at Birmingham and Charles Nichols, PhD, Professor of Pharmacology, Louisiana State University Health Sciences Center.

Audience: Pharmacologists and psychopharmacologists, toxicologists, biochemists, neurologists, psychiatrists, as well as addiction specialists, and regulators and policymakers.

Editorial Board Members
Jacob S Aday, PhD University Of California San Francisco, Berkeley, CA, USA
Brian Anderson, MD, MSC Univ Of California San Francisco, Forest Knolls, CA, USA
Elena M Argento, PhD, MPH University Of British Columbia, Gibsons, BC, Canada
Brian Barnett, MD Cleveland Clinic, Chesterland, OH, USA
Frederick Barrett, PhD Johns Hopkins University, Baltimore, MD, USA
Ann Berger, MD, MSN Expert Private Consultant, West Palm Beach, FL, USA
Randall Brown, MD, PhD University of Wisconsin, Madison, WI, USA
Clinton Canal, PhD Mercer University, Atlanta, GA, USA
Jeeshan H Chowdhury, MD, DPHIL Journey Colab, San Francisco, CA, USA
Kathryn A Cunningham, PhD, FASPET University of Texas Medical Branch, Galveston, TX, USA
Harriet de Wit  
Haley Dourron University Of Alabama At Birmingham, New Rochelle, NY, USA
Patrick Fisher, PhD Rigshospitalet Hospital, Copenhagen, Denmark
Albert Garcia-Romeu  
Grant Glatfelter, PhD National Institutes Of Health, Baltimore, MD, USA
Javier Gonzalez-Maeso, PhD Virginia Commonwealth University, Richmond, VA, USA
Charles Grob, MD University of California, Irvine, CA, USA
Cj Healy, MA New School For Social Research, New York, NY, USA
Peter Hendricks, PhD Univ Of Alabama At Birmingham Sc Of Med, Birmingham, AL, USA
Paul R Hutson, PHARMD, MS University of Wisconsin, Madison, WI, USA
Alaina M Jaster, BS Richmond, VA, USA
Hannah M Kramer, BS Louisiana State Uni Health Sciences Ctr, New Orleans, LA, USA
Jesper Kristensen, PhD University Of Copenhagen, New Rochelle, NY, USA
Natasha L Mason, PhD Maastricht University, Maastricht, USA
Kevin Murnane, PhD Louisiana State University, Shreveport, LA, USA
Christopher R Nicholas, PhD Univ Of Wisconsin Sch Of Med&Pub Health, Madison, WI, USA
Charles Nichols, PhD Lsu Health Sciences Center, New Orleans, LA, USA
David E Nichols, PhD Purdue University, West Lafayette, IN, USA
David Nutt, DM, FRCP, FRCPSYCH, FSB, FMEDSCI Imperial College London, UK
David E Olson, PhD Univ Of California Davis, Davis, CA, USA
Cynthia Ortiz, BA Univ Of Alabama At Birmingham, Birmingham, AL, USA
Jamie Peters, PhD University of Colorado, Aurora, CO, USA
Katrin Preller, MSC, PhD University of Zurich, Zurich, Switzerland
Shlomi Raz, MA Beckley Psytech Limited, Oxfordshire, United Kingdom
Bryan Roth, MD, PhD University of North Carolina, Chapel Hill, NC, USA
Caroline Sagrera, MD Louisiana State University, Shreveport, LA, USA
Otto Simonsson, PhD Karolinska Institute, Stockholm, Sweden
Mary Vest, PhD Louisiana State University, Shreveport, LA, USA
Zachary Walsh, PhD  
Bo J Wood, BS Louisiana State University, Shreveport, LA, USA